Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
Two stage study looking at different titration schedules in patients with moderate to severe
non-malignant chronic pain. Up to 80 patients at approximately 15 centers in the US to be
enrolled. Study participation is approximately 3 months.